Topchoice Medical Co., Inc.

XSSC:600763 Stock Report

Market Cap: CN¥21.9b

Topchoice Medical Valuation

Is 600763 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600763 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 600763 (CN¥49) is trading below our estimate of fair value (CN¥82.77)

Significantly Below Fair Value: 600763 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600763?

Key metric: As 600763 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 600763. This is calculated by dividing 600763's market cap by their current earnings.
What is 600763's PE Ratio?
PE Ratio45x
EarningsCN¥487.01m
Market CapCN¥21.92b

Price to Earnings Ratio vs Peers

How does 600763's PE Ratio compare to its peers?

The above table shows the PE ratio for 600763 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average58.3x
002044 Meinian Onehealth Healthcare Holdings
61.8x50.8%CN¥19.0b
600682 Nanjing Xinjiekou Department Store
39.1x34.1%CN¥9.8b
603882 Guangzhou Kingmed Diagnostics Group
92.2x44.9%CN¥14.9b
300962 Zhongjin Irradiation
40.1xn/aCN¥4.3b
600763 Topchoice Medical
45x16.7%CN¥21.9b

Price-To-Earnings vs Peers: 600763 is good value based on its Price-To-Earnings Ratio (45x) compared to the peer average (58.3x).

Price to Earnings Ratio vs Industry

How does 600763's PE Ratio compare vs other companies in the CN Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
600763 45.0xIndustry Avg. 32.9xNo. of Companies5PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 600763 is expensive based on its Price-To-Earnings Ratio (45x) compared to the CN Healthcare industry average (32.9x).

Price to Earnings Ratio vs Fair Ratio

What is 600763's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600763 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio45x
Fair PE Ratio27.2x

Price-To-Earnings vs Fair Ratio: 600763 is expensive based on its Price-To-Earnings Ratio (45x) compared to the estimated Fair Price-To-Earnings Ratio (27.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 600763 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥49.00
CN¥49.85
+1.7%
19.2%CN¥63.80CN¥30.00n/a9
Nov ’25CN¥50.36
CN¥47.33
-6.0%
20.6%CN¥63.80CN¥30.00n/a8
Oct ’25CN¥58.61
CN¥45.47
-22.4%
15.9%CN¥58.30CN¥32.10n/a8
Sep ’25CN¥43.42
CN¥46.00
+5.9%
15.4%CN¥58.30CN¥32.10n/a8
Aug ’25CN¥45.31
CN¥48.49
+7.0%
15.2%CN¥56.88CN¥32.10n/a8
Jul ’25CN¥39.90
CN¥49.33
+23.6%
14.6%CN¥56.88CN¥32.13n/a8
Jun ’25CN¥42.45
CN¥49.33
+16.2%
14.6%CN¥56.88CN¥32.13n/a8
May ’25CN¥43.40
CN¥52.70
+21.4%
26.4%CN¥80.68CN¥32.13n/a7
Apr ’25CN¥44.52
CN¥63.39
+42.4%
21.1%CN¥80.68CN¥42.12n/a7
Mar ’25CN¥47.19
CN¥63.39
+34.3%
21.1%CN¥80.68CN¥42.12n/a7
Feb ’25CN¥42.84
CN¥65.43
+52.7%
16.5%CN¥80.68CN¥49.98n/a7
Jan ’25CN¥54.58
CN¥71.16
+30.4%
16.4%CN¥90.59CN¥49.98n/a8
Dec ’24CN¥57.79
CN¥71.16
+23.1%
16.4%CN¥90.59CN¥49.98n/a8
Nov ’24CN¥64.16
CN¥71.16
+10.9%
16.4%CN¥90.59CN¥49.98CN¥50.368
Oct ’24CN¥62.97
CN¥80.28
+27.5%
15.1%CN¥93.61CN¥57.12CN¥58.618
Sep ’24CN¥66.26
CN¥82.40
+24.3%
15.0%CN¥99.96CN¥57.12CN¥43.4210
Aug ’24CN¥80.29
CN¥96.26
+19.9%
12.9%CN¥114.24CN¥71.40CN¥45.319
Jul ’24CN¥69.16
CN¥99.43
+43.8%
8.9%CN¥114.24CN¥81.79CN¥39.909
Jun ’24CN¥74.29
CN¥99.43
+33.8%
8.9%CN¥114.24CN¥81.79CN¥42.459
May ’24CN¥85.11
CN¥104.11
+22.3%
9.6%CN¥116.24CN¥85.68CN¥43.407
Apr ’24CN¥92.30
CN¥113.63
+23.1%
14.7%CN¥142.80CN¥85.68CN¥44.527
Mar ’24CN¥102.62
CN¥111.24
+8.4%
15.1%CN¥142.80CN¥85.68CN¥47.198
Feb ’24CN¥117.09
CN¥111.24
-5.0%
15.1%CN¥142.80CN¥85.68CN¥42.848
Jan ’24CN¥109.23
CN¥107.03
-2.0%
15.0%CN¥142.80CN¥85.68CN¥54.588
Dec ’23CN¥93.39
CN¥107.03
+14.6%
15.0%CN¥142.80CN¥85.68CN¥57.798
Nov ’23CN¥94.15
CN¥108.04
+14.8%
15.6%CN¥142.80CN¥85.68CN¥64.167

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.71

7D

-1.0%

1Y

39.5%

Winner Medical

CN¥19.7b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥33.84

7D

-1.3%

1Y

-14.3%

Chison Medical Technologies

CN¥3.0b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥26.68

7D

2.9%

1Y

-39.1%